Featured Reports
Corporate News and Events
CADTH Symposium: Springing Back to Spring in 2023
CADTH is preparing to bring back the usual time frame of the CADTH ...
Last Updated: August 8, 2022
Trace amine-associated receptor 1 (TAAR1) agonists are an emerging drug class in the treatment of schizophrenia. Currently available antipsychotic ...
Last Updated: July 15, 2022
A growing evidence base suggests that autologous hematopoietic stem cell transplantation (AHSCT) is a clinically effective emerging intervention for ...
Last Updated: May 17, 2021
Upcoming Events
Event date: Thursday, June 9, 2022
Time: 1:00 p.m. to 2:00 p.m. EDT
Zoom Webinar (Free — Registration Required)
Join Dr. Alexandra King and Mr ...
Event Date:
Event date: Friday, June 3, 2022
Time: 12:00 p.m. to 1:00 p.m. EDT
Zoom webinar (free although registration required)
Launched in 2014, Choosing ...
Event Date:
In the fall of 2021, CADTH published evidence and recommendations on the implementation of remote patient monitoring for cardiac conditions. The focus ...
Event Date:
Latest News
Held in April or May every year since 2005, the CADTH Symposium has traditionally been a spring event.
Because of the COVID-19 pandemic, the 2020 ...
Published on: July 13, 2022
CADTH is pleased to announce the successful collaborators of its inaugural Post-Market Drug Evaluation (PMDE) Network. Collaborators will bring ...
Published on: July 7, 2022
CADTH is pleased to announce the release of a new report entitled Building Toward a Potential Pan-Canadian Formulary: A Report From the Advisory Panel ...
Published on: June 30, 2022